You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Novitium Pharma Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NOVITIUM PHARMA, and what generic and branded alternatives to NOVITIUM PHARMA drugs are available?

NOVITIUM PHARMA has sixty-eight approved drugs.

There is one tentative approval on NOVITIUM PHARMA drugs.

Summary for Novitium Pharma
US Patents:0

Drugs and US Patents for Novitium Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novitium Pharma ALPRAZOLAM alprazolam TABLET;ORAL 074174-002 Oct 19, 1993 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Novitium Pharma SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 216383-002 Aug 29, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Novitium Pharma ESTRADIOL estradiol TABLET;ORAL 217334-002 Sep 6, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Novitium Pharma SIROLIMUS sirolimus SOLUTION;ORAL 211040-001 Jan 28, 2019 AA RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.